Decitabine
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Send inquiry
Replies slower than most
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Send inquiry
Not active
Send inquiry
Not active
Producer
+ 0
All certificates
Send inquiry
Not active
Send inquiry
Not active
Producer
+ 0
All certificates
Send inquiry
Not active
Looking for Decitabine 2353-33-5?
- API | Excipient name:
- Decitabine
- Synonyms:
- Azadc , Decitabine , Dezocitidine
- Cas Number:
- 2353-33-5
- DrugBank number:
- DB01262
- Unique Ingredient Identifier:
- 776B62CQ27
About Decitabine
More information about the use of: Decitabine. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic neoplasms with variable underlying etiology and presentation, including neutropenia and thrombocytopenia. Further mutations leading to increased proliferation of cancerous cells can eventually lead to secondary acute myeloid leukemia, which has a poor prognosis Among treatment options, nucleoside analogues such as decitabine and azacitidine integrate into cellular DNA and inhibit the action of DNA methyltransferases, leading to global hypomethylation and related downstream therapeutic benefits Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 2006.
It was first marketed under the name Dacogen®.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Decitabine manufacturers | traders | suppliers
We have 13 companies offering Decitabine from 3 different countries.
Get in contact with the supplier of your choice:
- Jiangsu Hansoh Pharma from China
- Qilu Pharma from China
- Sionc Pharma from India
- Reliance Life Sciences from India
- Wuhan Calmland from China
- Fresenius Kabi Onc. from India
- Zhejiang Hisun Pharma from China
- Intas Pharma from United Kingdom
- Sun Pharma from India
- MSN Labs. from India
- Biophore India from India
- Dr. Reddy's from India
- Emcure Pharma from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
